Drug Type Antibody drug conjugate (ADC)  | 
Synonyms 3H-10000  | 
Target  | 
Action inhibitors  | 
Mechanism FGFR2b inhibitors(fibroblast growth factor receptor 2 IIIb inhibitors)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhaseIND Approval  | 
First Approval Date-  | 
Regulation-  | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | IND Approval | China   | 28 Oct 2025 | 






